Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2007-8-6
pubmed:abstractText
Rat and mouse hemokinin-1(r/m hemokinin-1) is a recently described member of the tachykinin family whose cardiovascular functions are not fully understood. In this study, we investigated the mechanisms of the relaxing response induced by r/m hemokinin-1 in isolated porcine coronary arteries by using a specific antagonist of tachykinin NK(1) receptor (SR140333), a nitric oxide synthase inhibitor N(omega)-nitro-L-arginine (L-NNA), and 1H-[1,2,4] Oxadiazolo [4,3-a] quinoxalin-1-one (ODQ), a blocker of cGMP production. r/m Hemokinin-1 (10(-12)-10(-6 )M) evoked a marked endothelium-dependent vasodilatation (E(max)=121.12+/-10.6% and 91.79+/-2.39% in 10(-6) M PGF(2)alpha and 30 mM KCl precontracted arterial rings, respectively) of coronary arteries mediated by activation of endothelial tachykinin NK(1) receptors. Two components contributed to this r/m hemokinin-1-elicited vasodilatation, the first of which was endothelium-derived hyperpolarizing factor (EDHF), which played a major role. This EDHF was identified as a potassium current through certain kinds of potassium channels on the endothelial cell membrane of porcine coronary arteries. Specific antagonists of Ca(2+)-activated K(+) channels (dequalinium and clotrimazole) did not have an inhibitory effect on the r/m hemokinin-1-induced vasodilatation, whereas they did on the substance P-induced vasodilatation. When potassium ion efflux was impaired by a high K(+) concentration (30 mM) or removal of K(+) from the surroundings, NO synthesis was triggered by r/m hemokinin-1 to produce an equivalent EDHF (K(+))-independent vasorelaxation as a compensatory mechanism.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1H-(1,2,4)oxadiazolo(4,3-a)quinoxali..., http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents, Local, http://linkedlifedata.com/resource/pubmed/chemical/Clotrimazole, http://linkedlifedata.com/resource/pubmed/chemical/Dequalinium, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Neurotransmitter Agents, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitroarginine, http://linkedlifedata.com/resource/pubmed/chemical/Oxadiazoles, http://linkedlifedata.com/resource/pubmed/chemical/Piperidines, http://linkedlifedata.com/resource/pubmed/chemical/Potassium, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors, http://linkedlifedata.com/resource/pubmed/chemical/Quinoxalines, http://linkedlifedata.com/resource/pubmed/chemical/Quinuclidines, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neurokinin-1, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin, http://linkedlifedata.com/resource/pubmed/chemical/SR 140333, http://linkedlifedata.com/resource/pubmed/chemical/Substance P, http://linkedlifedata.com/resource/pubmed/chemical/Tac4 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Tachykinins, http://linkedlifedata.com/resource/pubmed/chemical/Tetraethylammonium, http://linkedlifedata.com/resource/pubmed/chemical/prostaglandin F2alpha receptor
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0014-2999
pubmed:author
pubmed:issnType
Print
pubmed:day
13
pubmed:volume
569
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
119-25
pubmed:meshHeading
pubmed-meshheading:17560993-Animals, pubmed-meshheading:17560993-Anti-Infective Agents, Local, pubmed-meshheading:17560993-Clotrimazole, pubmed-meshheading:17560993-Coronary Vessels, pubmed-meshheading:17560993-Dequalinium, pubmed-meshheading:17560993-Dose-Response Relationship, Drug, pubmed-meshheading:17560993-Endothelium, Vascular, pubmed-meshheading:17560993-Enzyme Inhibitors, pubmed-meshheading:17560993-Mice, pubmed-meshheading:17560993-Neurotransmitter Agents, pubmed-meshheading:17560993-Nitric Oxide, pubmed-meshheading:17560993-Nitroarginine, pubmed-meshheading:17560993-Oxadiazoles, pubmed-meshheading:17560993-Piperidines, pubmed-meshheading:17560993-Potassium, pubmed-meshheading:17560993-Potassium Channel Blockers, pubmed-meshheading:17560993-Protein Precursors, pubmed-meshheading:17560993-Quinoxalines, pubmed-meshheading:17560993-Quinuclidines, pubmed-meshheading:17560993-Rats, pubmed-meshheading:17560993-Receptors, Neurokinin-1, pubmed-meshheading:17560993-Receptors, Prostaglandin, pubmed-meshheading:17560993-Substance P, pubmed-meshheading:17560993-Swine, pubmed-meshheading:17560993-Tachykinins, pubmed-meshheading:17560993-Tetraethylammonium, pubmed-meshheading:17560993-Vasodilation
pubmed:year
2007
pubmed:articleTitle
Mechanisms of relaxing response induced by rat/mouse hemokinin-1 in porcine coronary arteries: roles of potassium ion and nitric oxide.
pubmed:affiliation
Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Institute of Biochemistry and Molecular Biology, Lanzhou University, 222 Tianshui South Road, Lanzhou, 730000, PR China.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't